40
Participants
Start Date
January 31, 1999
Primary Completion Date
April 30, 2002
filgrastim
recombinant interleukin-12
etoposide
ifosfamide
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Mount Sinai School of Medicine, New York
Sylvester Cancer Center, University of Miami, Miami
Arthur G. James Cancer Hospital - Ohio State University, Columbus
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
San Francisco General Hospital Medical Center, San Francisco
USC/Norris Comprehensive Cancer Center, Los Angeles
Massachusetts General Hospital, Boston
University Hospital/New Jersey Cancer Center, Newark
National Cancer Institute (NCI)
NIH